GPGI, CMPO Investors Face September 14 Deadline in Securities Class Action

Investors who purchased Class A common stock of GPGI, Inc., formerly known as CompoSecure, Inc. (NYSE: GPGI, CMPO), during the period from November 3, 2025, through May 6, 2026, face an important September 14, 2026 deadline in a securities class action.

The Rosen Law Firm, which focuses on investor rights and securities litigation, has reminded shareholders who purchased GPGI stock during the stated period that they may seek appointment as lead plaintiff in the case.

A lawsuit has already been filed. Investors who want to serve as lead plaintiff must ask the court for appointment by September 14. A lead plaintiff represents other members of the proposed class in directing the litigation.

Allegations in the GPGI Securities Case

According to the lawsuit, defendants allegedly made materially false or misleading statements during the proposed class period. The complaint also alleges that the company failed to disclose important information about the value and financial prospects of Husky.

The lawsuit claims that defendants materially overstated the value of Husky and that the business was not on track to meet revenue and Adjusted EBITDA targets outlined in a proxy statement.

The complaint further alleges that those targets lacked a reasonable basis in objective facts.

According to the allegations, the Husky acquisition also involved financial incentives for Resolute Holdings and individual defendants. The lawsuit claims these incentives influenced the transaction and that defendants therefore misrepresented the expected long-term value of the combined GPGI and Husky business.

$6 Billion Refinery Upgrade Pakistan Must Turn Investment Into Results

The allegations have not been proven in court. Investors should consider the lawsuit’s claims within the context of the ongoing legal proceedings.

Investors May Have Several Options

Investors who purchased GPGI Class A common stock during the Class Period may be eligible to participate in the proposed securities class action.

According to Rosen Law Firm, eligible investors may participate without paying upfront legal fees or expenses under a contingency-fee arrangement.

Investors do not have to become lead plaintiff to potentially participate in any future recovery. They may also remain absent members of the proposed class and take no action at this stage.

However, investors who want to seek lead plaintiff status must meet the September 14 court deadline.

No Class Has Yet Been Certified

The court has not yet certified the proposed class. Therefore, investors are not represented by counsel unless they separately retain an attorney.

Investors may choose their own legal counsel. They can also decide not to take action while the litigation proceeds.

The lead plaintiff deadline does not determine whether an investor can ultimately share in any potential recovery. It specifically concerns the process for selecting a representative to help direct the case.

Rosen Law Firm Urges Investors to Review Their Options

Rosen Law Firm is encouraging affected investors to carefully evaluate their legal representation before the deadline.

The firm says it focuses on securities class actions and shareholder derivative litigation and has represented investors internationally. It also cites past recoveries and industry recognition as part of its securities litigation experience.

The case remains ongoing, and the allegations contained in the complaint remain allegations unless and until established through the legal process.